ELIA SCL-70S IMMUNOASSAY
Oct 2014
245d
Phadia GmbH has submitted 1 FDA 510(k) premarket notifications since 2014, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Antinuclear Antibody (enzyme-labeled), Antigen, Controls . Use the specialty filter in the sidebar to narrow results.